Targeting protein-protein interaction interfaces in COVID-19 drug discovery

To date, the COVID-19 pandemic has claimed over 1 million human lives, infected another 50 million individuals and wreaked havoc on the global economy. The crisis has spurred the ongoing development of drugs targeting its etiological agent, the SARS-CoV-2. Targeting relevant protein-protein interact...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Comput Struct Biotechnol J
Auteurs principaux: Chang, Chung-ke, Lin, Shan-Meng, Satange, Roshan, Lin, Shih-Chao, Sun, Sin-Cih, Wu, Hung-Yi, Kehn-Hall, Kylene, Hou, Ming-Hon
Format: Artigo
Langue:Inglês
Publié: Research Network of Computational and Structural Biotechnology 2021
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064971/
https://ncbi.nlm.nih.gov/pubmed/33936565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2021.04.003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires